Camatte S, Deffieux X, Castaigne D, Thoury A, Fourchotte V, Pautier P, Lhommé C, Duvillard P, Morice P
Service de chirurgie, institut Gustave-Roussy, Villejuif, France.
Gynecol Obstet Fertil. 2005 Jun;33(6):395-402. doi: 10.1016/j.gyobfe.2005.04.022.
The aim of this study is to assess the clinical outcomes of laparoscopic treatment of borderline ovarian tumor (BOT).
Retrospective analysis of 54 patients treated using a laparoscopic approach for a BOT between January 1984 and January 2002.
A conservative management was initially performed in 45 patients (83%). Twenty-six patients underwent a reassessment surgery and 7 (27%) of them were upstaged following this procedure. Seven (13%) patients recurred in a remaining ovary following conservative surgery (5 patients) or on the peritoneum (2 patients). Three port-site localizations were observed. None of the patients treated with conservative management had recurrent disease under the form of ovarian carcinoma. Nine spontaneous pregnancies were observed in 6 patients from a group of 19 patients desiring pregnancy. All patients are today alive and disease-free.
Our study suggests that laparoscopic treatment could be safely performed in young patients with early stage BOT. Such procedure should be further evaluated in patients with BOT and peritoneal implants.
本研究旨在评估腹腔镜治疗卵巢交界性肿瘤(BOT)的临床效果。
回顾性分析1984年1月至2002年1月间采用腹腔镜方法治疗BOT的54例患者。
最初对45例患者(83%)实施了保守治疗。26例患者接受了再次评估手术,其中7例(27%)在此手术后分期升高。7例(13%)患者在保守手术后于对侧卵巢(5例患者)或腹膜(2例患者)复发。观察到3例端口部位复发。接受保守治疗的患者中无一例以卵巢癌形式出现复发性疾病。在一组19例有妊娠意愿的患者中,6例患者出现了9次自然妊娠。目前所有患者均存活且无疾病。
我们的研究表明,腹腔镜治疗对于早期BOT的年轻患者可安全实施。对于伴有腹膜种植的BOT患者,该手术应进一步评估。